U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Off-Patent Studies under BPCA
  1. Development Resources

Off-Patent Studies under BPCA

BPCA provides a mechanism for the National Institutes of Health (NIH) to identify drugs no longer under patent that need to be studied in children due to a lack of dosing, safety or efficacy data.  FDA works with the NIH to ensure that data from the clinical studies is considered for labeling modification.

Back to Top